Agnati L - Search Results

1

Effect of some phosphodiesterase inhibitors on central dopamine mechanisms.

Fredholm BB, Fuxe K, Agnati L. Fredholm BB, et al. Among authors: agnati l. Eur J Pharmacol. 1976 Jul;38(1):31-8. doi: 10.1016/0014-2999(76)90198-9. Eur J Pharmacol. 1976. PMID: 182507

2

The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity.

Fuxe K, Agnati LF, Ungerstedt U. Fuxe K, et al. Among authors: agnati lf. Eur J Pharmacol. 1976 Jan;35(1):93-108. doi: 10.1016/0014-2999(76)90304-6. Eur J Pharmacol. 1976. PMID: 943291

3

Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.

Fuxe K, Fredholm BB, Ogren SO, Agnati LF, Hökfelt T, Gustafsson JA. Fuxe K, et al. Among authors: agnati lf. Fed Proc. 1978 Jun;37(8):2181-91. Fed Proc. 1978. PMID: 350633 Review.

4

Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

Fuxe K, Fredholm BB, Agnati LF, Ogren SO, Everitt BJ, Jonsson G, Gustafsson JA. Fuxe K, et al. Among authors: agnati lf. Pharmacology. 1978;16 Suppl 1:99-134. doi: 10.1159/000136813. Pharmacology. 1978. PMID: 643908 No abstract available.

5

Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.

Fuxe K, Fredholm BB, Agnati LF, Corrodi H. Fuxe K, et al. Among authors: agnati lf. Brain Res. 1978 May 12;146(2):295-311. doi: 10.1016/0006-8993(78)90975-7. Brain Res. 1978. PMID: 647392

6

Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection.

Fuxe K, Andersson K, Locatelli V, Agnati LF, Hökfelt T, Skirboll L, Mutt V. Fuxe K, et al. Among authors: agnati lf. Eur J Pharmacol. 1980 Oct 17;67(2-3):329-31. doi: 10.1016/0014-2999(80)90521-x. Eur J Pharmacol. 1980. PMID: 7461038 No abstract available.

7

Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.

Fuxe K, Fredholm BB, Ogren SO, Agnati LF, Hökfelt T, Gustafsson JA. Fuxe K, et al. Among authors: agnati lf. Acta Endocrinol Suppl (Copenh). 1978;216:27-56. Acta Endocrinol Suppl (Copenh). 1978. PMID: 347864 Review. No abstract available.

8

Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats.

Bolme P, Fuxe K, Agnati LF, Bradley R, Smythies J. Bolme P, et al. Among authors: agnati lf. Eur J Pharmacol. 1978 Apr 1;48(3):319-24. doi: 10.1016/0014-2999(78)90090-0. Eur J Pharmacol. 1978. PMID: 639859

9

Pertussis toxin treatment counteracts intramembrane interactions between neuropeptide Y receptors and alpha 2-adrenoceptors.

Von Euler G, Fuxe K, Van der Ploeg I, Fredholm BB, Agnati LF. Von Euler G, et al. Among authors: agnati lf. Eur J Pharmacol. 1989 Dec 5;172(6):435-41. doi: 10.1016/0922-4106(89)90026-6. Eur J Pharmacol. 1989. PMID: 2558898

10

Vasopressor effects of substance P and C-terminal sequences after intracisternal injection to alpha-chloralose-anaesthetized rats: blockade by a substance P antagonist.

Fuxe K, Agnati LF, Rosell S, Härfstrand A, Folkers K, Lundberg JM, Andersson K, Hökfelt T. Fuxe K, et al. Among authors: agnati lf. Eur J Pharmacol. 1982 Jan 22;77(2-3):171-6. doi: 10.1016/0014-2999(82)90015-2. Eur J Pharmacol. 1982. PMID: 6174354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters